| P2093 | author name string | Imran Khan | |
| | Alpana Saxena | |
| | Gauri Gandhi | |
| | Prakash Chandra Ray | |
| | Mariyam Zuberi | |
| | Rashid Mir | |
| P2860 | cites work | miR-125b promotes cell proliferation by directly targeting Lin28 in glioblastoma stem cells with low expression levels of miR-125b. | Q53077362 |
| | The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer. | Q53220492 |
| | Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma. | Q53321450 |
| | Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis | Q84582500 |
| | Good guy or bad guy: the opposing roles of microRNA 125b in cancer | Q38207752 |
| | RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain | Q38439681 |
| | MicroRNA-125b may function as an oncogene in lung cancer cells | Q38468108 |
| | Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis. | Q38821536 |
| | PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b | Q38878699 |
| | MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer | Q38916573 |
| | MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma | Q38923147 |
| | MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases | Q39062231 |
| | miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1. | Q39493576 |
| | MicroRNA miR-125b is a prognostic marker in human colorectal cancer | Q39576859 |
| | MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab | Q39609757 |
| | MiR-125b targets BCL3 and suppresses ovarian cancer proliferation | Q39675974 |
| | Role of microRNAs in drug-resistant ovarian cancer cells | Q39934697 |
| | Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b | Q40207487 |
| | MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4. | Q40962436 |
| | Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. | Q42233721 |
| | miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer | Q42735024 |
| | The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα. | Q43134868 |
| | MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B | Q24564757 |
| | A coding-independent function of gene and pseudogene mRNAs regulates tumour biology | Q24632651 |
| | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 |
| | DNA methylation and microRNA dysregulation in cancer | Q26998741 |
| | Prediction of mammalian microRNA targets | Q27860498 |
| | Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells | Q28277441 |
| | Genetic unmasking of an epigenetically silenced microRNA in human cancer cells | Q28288806 |
| | MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis | Q28300240 |
| | Circulating MiR-125b as a marker predicting chemoresistance in breast cancer | Q28482362 |
| | Epigenetics in cancer | Q29547853 |
| | The colorectal microRNAome | Q29616082 |
| | MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo | Q34039589 |
| | Genetic variation in microRNA networks: the implications for cancer research | Q34177121 |
| | The role of microRNAs in ovarian cancer | Q34253436 |
| | Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis | Q34599169 |
| | Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome | Q34643344 |
| | MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways | Q35028282 |
| | Subtle variations in Pten dose determine cancer susceptibility | Q35055350 |
| | MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer | Q35128098 |
| | MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells | Q35550226 |
| | High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients | Q35678725 |
| | miR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development. | Q35769117 |
| | Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics | Q35882785 |
| | Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia | Q36070308 |
| | An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells | Q36288990 |
| | HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway | Q36375628 |
| | CpG island hypermethylation of tumor suppressor microRNAs in human cancer | Q36854202 |
| | MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1 | Q36962391 |
| | Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer | Q37002626 |
| | TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN | Q37347217 |
| | MicroRNA in prostate, bladder, and kidney cancer: a systematic review. | Q37836137 |
| | Cancer epigenetics reaches mainstream oncology | Q37851012 |
| | Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research | Q38183485 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | e0153902 | |
| P577 | publication date | 2016-04-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer | |
| P478 | volume | 11 | |